These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 19919784)

  • 1. MDR-TB in children: need for clear guidelines.
    Mohapatra PR; Khurana AK; Janmeja AK
    Int J Tuberc Lung Dis; 2009 Dec; 13(12):1578-9. PubMed ID: 19919784
    [No Abstract]   [Full Text] [Related]  

  • 2. Rational 'DOTS plus' for the control of MDR-TB.
    Espinal MA; Dye C; Raviglione M; Kochi A
    Int J Tuberc Lung Dis; 1999 Jul; 3(7):561-3. PubMed ID: 10423218
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro drug resistance and response to therapy in pulmonary tuberculosis patients under a DOTS programme in south India.
    Aparna SB; Reddy VC; Gokhale S; Moorthy KV
    Trans R Soc Trop Med Hyg; 2009 Jun; 103(6):564-70. PubMed ID: 19243801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
    Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of Estonian patients with primary multidrug-resistant versus drug-susceptible tuberculosis.
    Lockman S; Kruuner A; Binkin N; Levina K; Wang Y; Danilovitsh M; Hoffner S; Tappero J
    Clin Infect Dis; 2001 Feb; 32(3):373-80. PubMed ID: 11170944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.
    Kim HR; Hwang SS; Kim HJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
    Clin Infect Dis; 2007 Nov; 45(10):1290-5. PubMed ID: 17968823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of acquired MDR-TB and HIV co-infection.
    Deivanayagam CN; Rajasekaran S; Venkatesan R; Mahilmaran A; Ahmed PR; Annadurai S; Kumar S; Chandrasekar C; Ravichandran N; Pencillaiah R
    Indian J Chest Dis Allied Sci; 2002; 44(4):237-42. PubMed ID: 12437236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of multi-drug resistant tuberculosis: practitioner's view point.
    Prasad R
    Indian J Tuberc; 2007 Jan; 54(1):3-11. PubMed ID: 17455417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early and rapid microscopy-based diagnosis of true treatment failure and MDR-TB.
    Hamid Salim A; Aung KJ; Hossain MA; Van Deun A
    Int J Tuberc Lung Dis; 2006 Nov; 10(11):1248-54. PubMed ID: 17131784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Representative drug susceptibility patterns for guiding design of re-treatment regimens for multidrug-resistant tuberculosis in Iran.
    Tabarsi P; Nooraki A; Mirsaeidi M; Amiri M; Baghaei P; Farnia P; Kazempour M; Heidarnazhad H; Alipanah N; Mansouri D; Masjedi MR
    Respirology; 2008 Jan; 13(1):108-11. PubMed ID: 18197919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xpert® MTB/RIF diagnosed disseminated smear-negative MDR-TB in a sub-district hospital in India.
    Dorjee K; Salvo F; Dierberg KL
    Int J Tuberc Lung Dis; 2012 Nov; 16(11):1560-1. PubMed ID: 23044453
    [No Abstract]   [Full Text] [Related]  

  • 12. Acquisition of drug resistance in multidrug-resistant Mycobacterium tuberculosis during directly observed empiric retreatment with standardized regimens.
    Han LL; Sloutsky A; Canales R; Naroditskaya V; Shin SS; Seung KJ; Timperi R; Becerra MC
    Int J Tuberc Lung Dis; 2005 Jul; 9(7):818-21. PubMed ID: 16013781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired drug resistance in tuberculosis in Harayana, India.
    Janmeja AK; Raj B
    J Assoc Physicians India; 1998 Feb; 46(2):194-8. PubMed ID: 11273110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
    Migliori GB; Lange C; Girardi E; Centis R; Besozzi G; Kliiman K; Ortmann J; Matteelli A; Spanevello A; Cirillo DM;
    Clin Infect Dis; 2008 Mar; 46(6):958-9. PubMed ID: 18288911
    [No Abstract]   [Full Text] [Related]  

  • 15. Inadequacy of the current WHO re-treatment regimen in a central Siberian prison: treatment failure and MDR-TB.
    Kimerling ME; Kluge H; Vezhnina N; Iacovazzi T; Demeulenaere T; Portaels F; Matthys F
    Int J Tuberc Lung Dis; 1999 May; 3(5):451-3. PubMed ID: 10331736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
    Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
    J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of different subgroups of smear-positive retreatment patients under RNTCP in rural West Bengal, India.
    Mukherjee A; Sarkar A; Saha I; Biswas B; Bhattacharyya PS
    Rural Remote Health; 2009; 9(1):926. PubMed ID: 19260766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The "source" of drug-resistant TB outbreaks.
    van Helden PD; Victor T; Warren RM
    Science; 2006 Oct; 314(5798):419-20. PubMed ID: 17053131
    [No Abstract]   [Full Text] [Related]  

  • 19. Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?
    Gupta R; Raviglione MC; Espinal MA
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1078-9. PubMed ID: 11769764
    [No Abstract]   [Full Text] [Related]  

  • 20. Multidrug-resistant tuberculous meningitis in children in Durban, South Africa.
    Padayatchi N; Bamber S; Dawood H; Bobat R
    Pediatr Infect Dis J; 2006 Feb; 25(2):147-50. PubMed ID: 16462292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.